Results 31 to 40 of about 73,286 (248)

A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis-Associated Strains

mBio, 2023
Despite a high incidence of VVC, we still have a poor understanding of this female-specific disease whose negative impact on women’s quality of life has become a public health issue. It is not yet possible to determine by genotype or laboratory phenotype
A. Sala, A. Ardizzoni, Luca Spaggiari, Nikhil Vaidya, J. Van Der Schaaf, C. Rizzato, C. Cermelli, Selene Mogavero, Thomas Krüger, Maximilian Himmel, O. Kniemeyer, A. Brakhage, Benjamin L King, A. Lupetti, M. Comar, F. De Seta, A. Tavanti, E. Blasi, R. Wheeler, E. Pericolini   +19 more
semanticscholar   +1 more source

Antibacterial and antifungal treatment among patients with vulvovaginal candidiasis.

, 2022
Antibacterial and antifungal treatment among patients with vulvovaginal candidiasis.
Brendan R. Jackson (8575074), Kaitlin Benedict (8575071), Meghan Lyman (12476133)   +2 more
core   +1 more source

Prevalence, Associated Factors, and Appropriateness of Empirical Treatment of Trichomoniasis, Bacterial Vaginosis, and Vulvovaginal Candidiasis among Women with Vaginitis

Microbiology spectrum, 2023
Vaginal complaints are widespread among women and are associated with emotional, physical, and economic burdens with challenges in their diagnosis and management.
Sung-Hsi Huang, Heng-Cheng Hsu, Tai-Fen Lee, Hui-Min Fan, Chi-Wei Tseng, I. Chen, Hung Shen, Chia-Yi Lee, Hui-Ting Tai, Hong-Ming Hsu, Chien-Ching Hung   +10 more
semanticscholar   +1 more source

Dapagliflozin-Induced Vulvovaginitis in an Atopic Patient with Type 2 Diabetes Mellitus

Endocrinology Research and Practice, 2018
Dapagliflozin, an oral anti-diabetic agent, is a recently discovered sodium-glucose co-transporter receptor-2 inhibitor, which improves glycemic control by facilitating the renal excretion of glucose.
Narin NASIROĞLU İMGA, Merve ÇATAK, Dilek BERKER   +2 more
doaj   +1 more source

Demographic features, underlying conditions, and pre-diagnosis medications among patients with vulvovaginal candidiasis, recurrent vulvovaginal candidiasis, and females with an outpatient gynecologic visit.

, 2022
Demographic features, underlying conditions, and pre-diagnosis medications among patients with vulvovaginal candidiasis, recurrent vulvovaginal candidiasis, and females with an outpatient gynecologic visit.
Brendan R. Jackson (8575074), Kaitlin Benedict (8575071), Meghan Lyman (12476133)   +2 more
core   +1 more source

Population level of main microbiota and yeast-like Candida fungi in women with vulvovaginal candidiasis

Zaporožskij Medicinskij Žurnal, 2017
Aim - to determine population levels of main microbiota and yeast-like fungi of the genus Candida in healthy women and in women with vulvovaginal candidiasis. Materials and methods. For 10 years we have been surveyed 270 women in reproductive age from
N. D. Yakovychuk, S. Ye. Dejneka, I. I. Sydorchuk, L. I. Sydorchuk, A. V. Humenna, V. V. Bendas   +5 more
doaj   +1 more source

Evidence‐based update on Australasian pharmaceutical prescribing approaches for recurrent vulvovaginal candidiasis

, 2021
Recurrent vulvovaginal candidiasis (RVVC) is a subtype of vulvovaginal candidiasis, with debilitating effects on physical and emotional well-being affecting up to 10% of Australian women.
Evelin Tiralongo, Moira Bradfield Strydom, Tiralongo, Evelin, Walpola, Ramesh Lahiru, Strydom, Moira Bradfield, Robert S. Ware, Ramesh Lahiru Walpola, Khan, Sohil, Ware, Robert S, Sohil Khan   +9 more
core   +1 more source

Oteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: a multicenter, randomized, double-blinded, phase 3 trial

Antimicrobial Agents and Chemotherapy, 2023
Vulvovaginal candidiasis (VVC) is a common condition among women. Fluconazole remains the dominant treatment option for VVC. Oteseconazole is a highly selective inhibitor of fungal CYP51.
Xiao-Qian Wang, Lihong Chen, Hong-Jie Ruan, Z. Xiong, Wen-Ying Wang, Jin Qiu, Weihua Song, Chun-Lian Zhang, Fengxia Xue, Tianhua Qin, Bei Zhang, Ruifang An, Xi-Ping Luo, Wei Wang, Song-Ling Zhang, Yunlang Cai, Jia-Li Kang, H. Deng, Shang-Rong Fan, M. Cui, Shijin Wang, Xiao-Wan Luo, Zhiying Su, Jing Shu, Quan-Ren Wang, Fang Wang, Jianling Bai, Qin-Ping Liao   +27 more
semanticscholar   +1 more source

Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome

Microbiology spectrum, 2023
Fungi headed by C. albicans play a critical role in VVC but are not sufficient for its occurrence, indicating the involvement of other factors, such as the vaginal bacteriome.
Changying Zhao, Y. Li, Bin Chen, Kaile Yue, Zhenzhen Su, Jing Xu, Wanhua Xue, Guoping Zhao, Lei Zhang   +8 more
semanticscholar   +1 more source

Immunopathogenesis of recurrent vulvovaginal candidiasis [PDF]

Clinical Microbiology Reviews, 1996
Recurrent vulvovaginal candidiasis (RVVC) is a prevalent opportunistic mucosal infection, caused predominantly by Candida albicans, which affects a significant number of otherwise healthy women of childbearing age. Since there are no known exogenous predisposing factors to explain the incidence of symptomatic vaginitis in most women with idiopathic ...
P L, Fidel, J D, Sobel
openaire   +3 more sources